CDC
201 - 220 of 549 Results
-
-
Boost Now or Wait? Many Wonder How Best to Ride Out Covids Next Wave
As the country faces a rise in new infections driven by the omicron BA.5 subvariant of the coronavirus, about 70% of people 50 and older who got a first covid-19 booster shot haven't received the recommended second one, according to the Centers for Disease Control and Prevention. Many undervaccinated Americans have lost interest, and others arent sure whether to get boosted again now or wait for vaccines reformulated to target newer strains of the virus.
By Sam Whitehead and Arthur Allen -
A Free-for-All From Readers and Tweeters, From Medical Debt to Homelessness
KHN gives readers a chance to comment on a recent batch of stories.
-
Hospital-Acquired Pneumonia Is Killing Patients. Yet There Is a Simple Way to Stop It.
Hospital-acquired pneumonia not tied to ventilators is one of the most common infections that strike within health care facilities. But few hospitals take steps to prevent it, which can be as simple as dutifully brushing patients teeth.
By Brett Kelman -
Vaccine and Testing Delays for Monkeypox Echo Failures in Early Covid Response
Public health officials say monkeypox is not as dangerous as covid and can be handled well with current treatments and if those at risk use caution. But the rollout of vaccines has been slow and led to angst among some at-risk people.
-
Feds Want a Policy That Advocates Say Would Let Hospitals Off the Hook for Covid-Era Lapses
The pandemic disrupted all sense of normalcy for U.S. hospitals, so federal officials are proposing to pause financial penalties against the facilities and to block public access to key hospital safety data such as the frequency of falls and sepsis because of concerns that the data isnt accurate enough. But consumer advocates are furious about the proposal.
By Lauren Weber -
How Pfizer Won the Pandemic, Reaping Outsize Profit and Influence
The drugmaker has the best-selling vaccine to prevent covid and the most effective drug to treat it. Its success has overshadowed the governments covid-fighting strategy.
By Arthur Allen -
Montanas Blackfeet Tribe to Use Dogs to Sniff Out Disease and Contaminants
The Blackfeet Nation is experimenting with a new way to detect chronic wasting disease in animals used by tribal members for food and cultural practices.
-
What You Need to Know About Monkeypox
For now, monkeypox poses a low risk to the U.S. public, but it could become a problem if the spread is left unchecked. Heres what everyone should know about it.
-
Readers and Tweeters Weigh In on Medical Debt, the Obesity Epidemic, and Opioid Battles
KHN gives readers a chance to comment on a recent batch of stories.
-
Perspective
Will the US Overcome Its Covid Complacency Even as the Threat Returns?
One million Americans have died from covid-19 far more per capita than in any other developed country. A new variant is doubling case rates in some states, and more than 300 people are dying a day. But our nations pandemic response has become mild-mannered and performative, backed by neither money, urgency, nor enforcement.
-
Covid Funding Pries Open a Door to Improving Air Quality in Schools
Researchers say the billions in pandemic funding available for ventilation upgrades in U.S. schools provides a once-in-a-generation opportunity to combat covid-19, as well as making air more breathable for students living with allergies, asthma, and chronic wildfire smoke.
By Liz Szabo -
Grassroots Groups Lead Way on Closing Colorados Infant Mortality Gap
Colorado is among about 15 states that have met federal goals to reduce infant mortality, an important indicator of overall population health. Breaking down the data by race and ethnicity, though, makes clear that major gaps remain.
-
Childrens Vision Problems Often Go Undetected, Despite Calls for Regular Screening
Eye exams for children are required under federal law to be covered by most private health plans and Medicaid, and many states mandate school vision screenings. But a federal survey finds that a quarter of children and teens are still not getting the recommended tests.
-
KHNs What the Health?: Washingtons Slow Churn
Stemming gun violence is back on the legislative agenda following three mass shootings in less than a month, but its hard to predict success when so many previous efforts have failed. Meanwhile, lawmakers must soon decide if they will extend current premium subsidies for those buying health insurance under the Affordable Care Act, and the Biden administration acts, belatedly, on Medicare premiums. Margot Sanger-Katz of the New York Times, Sandhya Raman of CQ Roll Call, and Rachel Cohrs of Stat News join KHNs Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHNs Michelle Andrews, who reported and wrote the latest KHN-NPR Bill of the Month episode about a too-common problem: denial of no-cost preventive care for a colonoscopy under the Affordable Care Act.
-
Readers and Tweeters Go to the Mat on Abortion Rights and Perceived Wrongs
KHN gives readers a chance to comment on a recent batch of stories.
-
Watch: Going Beyond the Script of The G Word and How Government Responds to Disease (Or Not)
KHN Editor-in-Chief Elisabeth Rosenthal joins comedian Adam Conover to discuss his new Netflix series, The G Word, which examines the federal government's role in Americans' lives, and how it plays out in the covid era.
-
Thats Just Part of Aging: Long Covid Symptoms Are Often Overlooked in Seniors
Millions of older adults are grappling with long covid, yet the impact on them has received little attention even though research suggests seniors are more likely to develop the poorly understood condition than younger or middle-aged adults.
-
How Better Ventilation Can Help Covid-Proof Your Home
Is someone at home sick with covid-19? One simple but effective strategy for keeping the virus from spreading is to make your indoor air as much like the outdoors as possible.
By Liz Szabo -
States Have Yet to Spend Hundreds of Millions of Federal Dollars to Tackle Covid Health Disparities
A year ago, the Centers for Disease Control and Prevention awarded states and local health departments $2.25 billion to help people of color and other populations at higher risk from covid. But a KHN review shows public health agencies across the country have been slow to spend it.